Norges Bank’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-125,927
Closed -$10.1M 607
2025
Q4
$10.1M Buy
+125,927
New +$8.46M ﹤0.01% 1304
2025
Q3
Sell
-493,520
Closed -$36.8M 675
2025
Q2
$36.8M Sell
493,520
-18,490
-4% -$1.22M ﹤0.01% 1063
2025
Q1
$32.5M Buy
512,010
+91,894
+22% +$6.25M ﹤0.01% 1100
2024
Q4
$32.8M Sell
420,116
-68,450
-14% -$5.5M ﹤0.01% 1119
2024
Q3
$39.3M Buy
488,566
+3,851
+0.8% +$311K 0.01% 1052
2024
Q2
$40.1M Buy
484,715
+11,561
+2% +$1.02M 0.01% 995
2024
Q1
$40.4M Buy
473,154
+138,797
+42% +$10.9M 0.01% 1039
2023
Q4
$28.6M Buy
334,357
+105,408
+46% +$9.11M 0.01% 1156
2023
Q3
$20.5M Buy
228,949
+50,059
+28% +$4.47M ﹤0.01% 1222
2023
Q2
$15.2M Sell
178,890
-221,871
-55% -$18.8M ﹤0.01% 1373
2023
Q1
$33.2M Sell
400,761
-30,668
-7% -$2.48M 0.01% 1026
2022
Q4
$33.9M Buy
431,429
+41,519
+11% +$3.34M 0.01% 1000
2022
Q3
$28.9M Buy
389,910
+5,605
+1% +$402K 0.01% 1031
2022
Q2
$25M Buy
384,305
+2,534
+0.7% +$150K 0.01% 1131
2022
Q1
$24.1M Hold
381,771
0.01% 1294
2021
Q4
$20.2M Sell
381,771
-694
-0.2% -$42.3K ﹤0.01% 1469
2021
Q3
$27M Sell
382,465
-111,844
-23% -$7.06M 0.01% 1291
2021
Q2
$32.9M Buy
494,309
+63,892
+15% +$4.52M 0.01% 1213
2021
Q1
$47.8M Sell
430,417
-72,952
-14% -$9.03M 0.01% 998
2020
Q4
$59.8M Sell
503,369
-14,398
-3% -$1.55M 0.01% 854
2020
Q3
$45.2M Sell
517,767
-78,469
-13% -$6.86M 0.01% 893
2020
Q2
$53.4M Sell
596,236
-125,823
-17% -$12.7M 0.02% 790
2020
Q1
$72M Hold
722,059
0.03% 549
2019
Q4
$83M Sell
722,059
-58,463
-7% -$7.07M 0.02% 630
2019
Q3
$98.5M Hold
780,522
0.03% 520
2019
Q2
$93.9M Sell
780,522
-23,180
-3% -$2.28M 0.03% 544
2019
Q1
$70.3M Hold
803,702
0.02% 651
2018
Q4
$80.4M Hold
803,702
0.03% 527
2018
Q3
$92.1M Sell
803,702
-37,038
-4% -$3.83M 0.03% 537
2018
Q2
$75.4M Sell
840,740
-112,633
-12% -$9.51M 0.03% 602
2018
Q1
$69.7M Hold
953,373
0.03% 620
2017
Q4
$55.4M Sell
953,373
-19,840
-2% -$1.04M 0.02% 739
2017
Q3
$43.7M Buy
973,213
+110,089
+13% +$4.57M 0.02% 873
2017
Q2
$34.1M Buy
863,124
+352,879
+69% +$14.5M 0.01% 1022
2017
Q1
$20.7M Hold
510,245
0.01% 1370
2016
Q4
$20.5M Buy
510,245
+135,768
+36% +$5.12M 0.01% 1286
2016
Q3
$13M Sell
374,477
-92,940
-20% -$3.19M 0.01% 1503
2016
Q2
$13.6M Buy
467,417
+9,900
+2% +$299K 0.01% 1444
2016
Q1
$16M Hold
457,517
0.01% 1296
2015
Q4
$14.8M Sell
457,517
-52,742
-10% -$1.71M 0.01% 1349
2015
Q3
$16.5M Hold
510,259
0.01% 1243
2015
Q2
$21.1M Hold
510,259
0.01% 1167
2015
Q1
$22.9M Buy
510,259
+30,993
+6% +$1.3M 0.01% 1121
2014
Q4
$17.9M Hold
479,266
0.01% 1282
2014
Q3
$16.7M Sell
479,266
-263,902
-36% -$9.42M 0.01% 1259
2014
Q2
$26.2M Buy
743,168
+371,584
+100% +$12.4M 0.01% 1465
2014
Q1
$12.1M Hold
371,584
0.01% 1477
2013
Q4
$15.7M Hold
371,584
0.01% 1290
2013
Q3
$14.8M Buy
371,584
+144,305
+63% +$6.05M 0.01% 1295
2013
Q2
$9.4M Buy
+227,279
New +$9.2M 0.01% 1506

Other funds holding HAE

Norges Bank's HAE Position: Q1 2026 in Review

Norges Bank sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 125,927 shares — an estimated $10.1M sold.

Norges Bank first reported a position in HAE in Q2 2013 and held it in 50 quarters. The position peaked at $98.5M in Q3 2019. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Norges Bank reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 125,927 Haemonetics shares in Q1 2026, an estimated $10.1M.
  • Norges Bank first reported a position in Haemonetics in Q2 2013 and held it in 50 quarters.
  • Norges Bank's Haemonetics position peaked at $98.5M in Q3 2019.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.